Form D · Other Technology
Agilis Chemicals, Inc.
Newark, NJ · CIK 0001826508
Offering snapshot reported Sep 30, 2020 · SEC filing
- Reported sold
- $3.65M Offering amount: $3.65M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Aug 26, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 30, 2020 | Initial | $3,650,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-376769
Source: Form D, filed Sep 30, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jayesh M. Bhatia | Executive |
| Anna Garcia | Director |
| David Grimes | Executive |
| Krishnamurty Kambhampati | Director |
| Ye Wang | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1 Washington Park, 7 Th Floor
Newark, NJ, 07102
Newark, NJ, 07102